Smart & Biggar is Canada's largest firm practicing exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montréal, Vancouver and Calgary. We are leaders in intellectual property and have been serving clients for over a century.
Intellectual property rights are only valuable if they can be protected and exploited intelligently. At Smart & Biggar we are devoted to maximizing the value of our clients' intellectual property and technology assets. While we are proud that we have been selected repeatedly as Canada's leading intellectual property firm in numerous Canadian and international surveys, we recognize that our success is best measured by your success.
Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms.
For more information, please visit https://www.smartbiggar.ca/
On April 2, 2020, the Patented Medicine Prices Review Board (PMPRB) published a message from the Chairperson regarding the results of its consultation on the draft Guidelines operationalizing the...
To print this article, all you need is to be registered or login on Mondaq.com.
On April 2, 2020, the Patented Medicine Prices Review Board
(PMPRB) published a message from the Chairperson
regarding the results of its consultation on the draft Guidelines
operationalizing the amended Patented Medicines
Regulations (reported
here). The PMPRB will be making "significant changes"
to the draft Guidelines in response to the feedback it received
during the consultation and intends to publish a revised draft for
comment this spring. The Chairperson further noted that, in view of
COVID-19, the PMPRB would reassess the intended next steps closer
to the date of their publication.
On April 15, 2020, the PMPRB published six additional
stakeholder submissions that had been inadvertently omitted from
the set of submissions previously published on its consultation
portal (reported
here).
Originally published 30 April, 2020
The preceding is intended as a timely update on Canadian
intellectual property and technology law. The content is
informational only and does not constitute legal or professional
advice. To obtain such advice, please communicate with our offices
directly.
PMPRB News: "Significant Changes" To Be Made To Draft Pricing Guidelines
CanadaFood, Drugs, Healthcare, Life Sciences
Contributor
Smart & Biggar is Canada's largest firm practicing exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montréal, Vancouver and Calgary. We are leaders in intellectual property and have been serving clients for over a century.
Intellectual property rights are only valuable if they can be protected and exploited intelligently. At Smart & Biggar we are devoted to maximizing the value of our clients' intellectual property and technology assets. While we are proud that we have been selected repeatedly as Canada's leading intellectual property firm in numerous Canadian and international surveys, we recognize that our success is best measured by your success.
Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms.
For more information, please visit https://www.smartbiggar.ca/
